Featured Research

from universities, journals, and other organizations

Endocrine-disrupting chemicals pose global health threat, experts say

Date:
September 19, 2013
Source:
Endocrine Society
Summary:
Endocrine experts agreed that endocrine-disrupting chemicals (EDCs) pose a threat to human health and to the ecosystems of Earth. The editorial comes in response to a commentary (Dietrich et al. Chem Biol Interact) signed by a number of editors of toxicology journals that dismisses the state-of-the-science on EDCs and argues for the status quo in the regulation of these hazardous substances.

In an editorial published in Endocrinology, a journal of The Endocrine Society, endocrine experts agreed that endocrine-disrupting chemicals (EDCs) pose a threat to human health and to the ecosystems of Earth. The editorial comes in response to a commentary (Dietrich et al. Chem Biol Interact) signed by a number of editors of toxicology journals that dismisses the state-of-the-science on EDCs and argues for the status quo in the regulation of these hazardous substances.

EDCs* are commonly found in food and food containers, plastic products, furniture, toys, carpeting, building materials, and cosmetics. They are often released from the products that contain them and enter the bodies of humans and wildlife through dust or through the food chain. A large volume of studies have shown that EDCs exert their effects by interfering with endogenous hormone action and can impact male and female reproduction, breast development and cancer, prostate cancer, neuroendocrinology, thyroid, metabolism and obesity, and cardiovascular endocrinology.

"The Dietrich et al. paper neglects the fundamental principles of how the endocrine system works and how chemicals can interfere with its normal function, nor does it consider the consequences of that interference," said Andrea Gore, PhD, lead author of the editorial and Editor-in-Chief of Endocrinology. "We cannot have sound policies for regulating these chemicals when we ignore the science."

The Endocrinology editorial, Gore et al., represents an unprecedented response from the endocrine community. The editorial was signed by 20 editors-in-chief and 28 associate and senior editors of endocrine, neuroendocrine, environmental, and other peer-reviewed journals. Dr. Teresa Woodruff, PhD, President of The Endocrine Society and several other presidents of societies or medical organizations have also signed on to the editorial.

The Endocrine Society has published a Scientific Statement on EDCs -- a thorough review of the literature, with recommendations for improved policy -- and a Statement of Principles -- a summary of critical endocrine principles that are relevant to risk assessment as it applies to EDCs. In its Statement of Principles, the Society recommends that endocrine principles be incorporated into programs by the EPA and other agencies charged with evaluating chemicals for endocrine-disrupting potential.

"Regulatory decisions on the use of EDCs should be made based on the best available science and expertise that involves among others, reproductive biology, endocrinology, medicine, genetics and toxicology," said Gore.

*According to the National Institute of Environmental Health Sciences, a wide range of substances, both natural and human-made, are thought to cause endocrine disruption, including pharmaceuticals, dioxin and dioxin-like compounds, polychlorinated biphenyls (PCBs), DDT and other pesticides, and plasticizers such as bisphenol A.


Story Source:

The above story is based on materials provided by Endocrine Society. Note: Materials may be edited for content and length.


Journal References:

  1. Andrea Gore et al. Policy Decisions on Endocrine Disruptors Should Be Based on Science Across Disciplines: A Response to Dietrich et al.. Endocrinology, 2013 DOI: 10.1016/j.fct.2013.07.005
  2. R. T. Zoeller, T. R. Brown, L. L. Doan, A. C. Gore, N. E. Skakkebaek, A. M. Soto, T. J. Woodruff, F. S. Vom Saal. Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society. Endocrinology, 2012; 153 (9): 4097 DOI: 10.1210/en.2012-1422

Cite This Page:

Endocrine Society. "Endocrine-disrupting chemicals pose global health threat, experts say." ScienceDaily. ScienceDaily, 19 September 2013. <www.sciencedaily.com/releases/2013/09/130919121900.htm>.
Endocrine Society. (2013, September 19). Endocrine-disrupting chemicals pose global health threat, experts say. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2013/09/130919121900.htm
Endocrine Society. "Endocrine-disrupting chemicals pose global health threat, experts say." ScienceDaily. www.sciencedaily.com/releases/2013/09/130919121900.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins